Headlines:
- Ivermectin has been approved for use in treating Covid-19 in South Africa on a limited basis.
- South Africa has approved AstraZeneca’s Covid-19 vaccine for emergency use and is reviewing applications by rival manufacturers, Johnson & Johnson and Pfizer, the medicines regulator said on Wednesday.
- Administrators at national airline SAA received R1.3bn ($85.36m) from the Department of Public Enterprises last week, a spokeswoman for the administrators said on Wednesday.
- Bitcoin’s price could exceed $50,000 over the longer term as the digital asset vies with gold for investment flows, according to cryptocurrency exchange Luno – which says it has at least 3m traders in its books in South Africa.
- Steinhoff jumps.
Listen on iTunesÂ
